Tiphaine Vidal-Trécan

High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold

Laurent Castéra, Cédric Laouenan, Anaïs Vallet‐Pichard et al. · Diabetes Care · 2023 · 123 citations · Full text

Medicine, Internal Medicine, Pathology +17

Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: The AngioSafe Type 2 Diabetes Study

Bénédicte Gaborit, Jean‐Baptiste Julla, Samaher Besbes et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 91 citations · Full text

Medicine, Endocrinology, Ophthalmology +17

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes

Fawaz Alzaïd, Jean‐Baptiste Julla, Marc Diedisheim et al. · EMBO Molecular Medicine · 2020 · 59 citations · Full text

Life Sciences, Immunology, Pathology +17

Acquired generalized lipodystrophy under immune checkpoint inhibition

N. Haddad, Tiphaine Vidal-Trécan, Barouyr Baroudjian et al. · British Journal of Dermatology · 2019 · 53 citations

Life Sciences, Immunology, Oncology +17

Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes

Laurent Castéra, Philippe Garteiser, Cédric Laouenan et al. · Journal of Hepatology · 2024 · 45 citations

Medicine, Endocrinology, Internal Medicine +7